InvestorsHub Logo
Followers 33
Posts 1927
Boards Moderated 1
Alias Born 08/02/2019

Re: None

Friday, 06/23/2023 12:57:42 PM

Friday, June 23, 2023 12:57:42 PM

Post# of 403217
If you want to attack a small biotech company like Ipix you must start with one question. Is the company science good or not good?

If the science is not good the job is easy. Learn everything possible and demonstrate the science is not good. Tell everyone the bad evidence. It should be finished quickly if the science is not good.

If the science is good it is more work. Creativity is maybe necessary in the attack. Here are some options.
> The science is maybe not safe. This can be effective if the drug has not advance more than a Phase 2.clinical test.
> The company management is stupid or criminal or both. All small companies make mistakes. Find the mistakes and build a story in corruption and foolishness.
> The company will run out of money and fail. Every small biotech like Ipix needs a partner to go forward. If there is no partner and little money it is possible to build disappointment and despair for a good story.
> The market for the science is too small. Not enough people need the drug and no one will make any money. This one will not work well for Ipix and Brilacidin. But it is worth to try.

The Brilacidin science is good and independent research continues and for now Ipix is super cheap to buy. This will change. My opinion that Brilacidin is worth USD$1.50 or more par share is not changed.
https://www.google.com/search?q=google+scholar+brilacidin&client=firefox-b-1-d&sxsrf=APwXEdcD79IEfldrmCDYhcHwJZCW0Hh2Uw:1687539423620&tbas=0&source=lnt&sa=X&ved=2ahUKEwjDp46f7tn_AhXFg4QIHfBMAY4QpwV6BAgBEAY&biw=1358&bih=617&dpr=1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News